From Tuesday 1st September the Minor Ailments Service is once again available at community pharmacies. The service supports patients to manage and treat a range of minor ailments under the professional healthcare guidance of a community pharmacist. The service is accessible without an appointment and a list conditions can be found at http://www.hscbusiness.hscni.net/2055.htm
If you have any query about this service, please contact your
local HSCB Pharmacy Adviser or the CPNI Office.
A recently published survey by epilepsy charities Epilepsy Action, Epilepsy Society and Young Epilepsy found one in ten (11%) women who are currently taking the epilepsy medicine valproate are unaware of the possible risk of birth defects if taken in pregnancy. Furthermore, one in five (18%) don’t know that, when taken in pregnancy, the medicine could also cause learning and developmental delays in children.
Under the current regulations, valproate must
no longer be used for women and girls who are able to become pregnant unless
there is a Pregnancy Prevention Plan (PPP) in place. The PPP, mandatory at
prescription, is an intervention from the MHRA designed to make sure patients
are fully aware of the risks of valproate use in pregnancy and the need to
avoid becoming pregnant.
The survey found that many women with epilepsy
are still not receiving information from health professionals about the risks
of valproate, leaving their potential future children at risk of harm.
” Valproate dispensing from the pharmacist
Just under half of respondents (49%, 251/514) said they had had no discussion with their pharmacist about the risks associated with taking valproate during pregnancy. Only 14% (72/514) said they had this discussion every time they collected a prescription.
29% (150/514) of respondents stated that when their valproate was dispensed in a plain package, the box never had a sticker with the warning pictogram. Only 60% (306/514) of respondents stated that a prescription in a manufacturer’s packaging always included the warning pictogram.
Over half (51%, 261/514) of respondents said they had never received the Patient Card from their pharmacist when receiving their prescription “
PHARMACISTS are asked to take the following IMPORTANT ACTIONS:
Provide a Patient Card every time you dispense a valproate medicine to ALL female patients. Please also note that the outer boxes of valproate are being changed in order to include a removable patient card, to be detached and given to the female patient at the time of dispensation.
When dispensing any valproate preparation to female children, adolescents, women of childbearing potential, or pregnant women check that their prescriber has discussed the risks of exposure in pregnancy with them and they are aware of these and subsequently they are taking effective contraception unless already pregnant.
If the prescriber has not discussed the risks with the patient or the patient is not taking effective contraception, tell them to contact their GP or specialist for an urgent follow-up appointment.
Advise the patients not to stop valproate medication and to immediately contact their GP or specialist in case of suspected pregnancy.
Ask if they have received the Patient Guide and provide a copy if they have not received this or no longer have it in their possession.
Dispense valproate in the original package with the outer warning and avoid repacking. In the situations where this cannot be avoided, always provide a copy of the package leaflet, patient card, and add a warning sticker to the outer box.
To order new or further PPP materials, please contact Sanofi
medical information department on 0845 372 7101 or email UK-Medicalinformation@sanofi.com.
Community Pharmacy can play a leading role in the re-building of the Health and Social Care sector as COVID -19 surge plans reduce.
The Chief Executive of Community Pharmacy NI, Gerard Greene, has said that the community pharmacy network here can provide significant support in getting the health and social care system back on its feet after COVID -19 surge plans have been downgraded.
The call comes as the Health Minister Robin Swann has announced that he will be bringing forward a strategic framework for the re-establishment of the health service after it adapted to accommodate the system to prepare for hundreds of COVID -19 patients to be admitted to hospital.
The representative body has said that community pharmacists already play
an enhanced role in transforming our health service and that now is the
opportunity to invest further in the network as the current crisis gradually
lifts.
Gerard Greene, Chief Executive of Community Pharmacy NI said:
“We are only too aware of the unrelenting pressures that the entire health service has been placed under during the darkest moments of the spread of COVID-19. We are not out of the woods as yet, but the Minister and Department have a difficult job on their hands in piecing back together elements of the health service that had to be dismantled to accommodate a worst case scenario.”
“Prior to the COVID-19 outbreak, waiting times at the likes of GP surgeries were significant and the health service was under visible strain. During the recent weeks and months, it is apparent that the community pharmacy network stepped up massively and adapted almost overnight to keep the flow of vital medicines to patients managing conditions in addition to those presenting symptoms at pharmacies who were unable to access their GP.”
“We know that with the right resourcing and financial backing that pharmacists can do so much more to alleviate bottlenecks. The Minister has stated that there is a clear opportunity to make a number of improvements and we are keen to work with the Department to ensure that any investment in community pharmacy is one that works to help transform the health service. If we do not invest in transformative services, then we are putting public health at risk.”
Serious Shortage Protocol: Important information
You will have received recently a communication from the Department of Health NI in respect of a Serious Shortage Protocol (SSP) relating to fluoxetine 10mg tablets which was issued by the Department of Health England.
DHNI has confirmed that, although the SSP issued states that it applies to Northern Ireland, this is not the case. The SSP is not operational here but may be activated at a future date. If a decision is taken to activate the SSP at a future date, further communication will issue from the DHNI.
Action
Contractors should:
Make their dispensing teams aware that this serious shortage protocol is not applicable to Northern Ireland; and
Access the weblink below regularly to check the status of SSPs in Northern Ireland. This website also contains useful guidance on how to dispense under an SSP.
The CPNI will continue to support and inform contractors in the event that SSPs are rolled out here.
Serious Shortage Protocols (SSPs): Issue of guidance.
In early 2019, following consultation, changes to the Human Medicines Regulations were made to allow the introduction of Serious Shortage Protocols (SSPs) in the event of a serious shortage of medicines. The necessary changes to the Northern Ireland Pharmaceutical Regulations came into force on 31 October 2019.
This guidance includes form SSP/F/01 which can be downloaded to facilitate the notification of prescribers where necessary. (Remember that notification of the prescriber is only required where a supply is made to a patient for a therapeutic equivalent or when notification of the prescriber is required under the terms of a specific SSP). It is not a requirement to use this form and other means of notifying prescribers may be used. Contractors should consider keeping a record of all such notifications. A copy of FAQs and a patient information leaflet will also be made available on the BSO website.
The intention is that an SSP will be issued only if a medicine has been judged by Ministers to be in serious short supply. The SSP will set out a clear protocol for community pharmacists to follow if they are unable to source that medicine for patients who have been prescribed it.
Contractors will be notified of the issuing of SSPs applicable to Northern Ireland in a number of ways:
• Business Service Organisation’s website http://www.hscbusiness.hscni.net/services/3063.htm – this dedicated section on the BSO website will contain details of all SSPs. For ease, new SSPs or amended existing SSPs will be flagged; • Contractors will be advised by the HSCB when a new SSP is published, or when an amendment is made to an existing SSP, and this will include a link to the BSO website; • Information on SSPs is expected to appear within Trade journals (for example, Chemist and Druggist or the Pharmaceutical Journal) and their associated websites; and • CPNI website – issue of, and updates to, SSPs operating in Northern Ireland will be highlighted on the CPNI website.
Action Contractors and pharmacists are advised to:
• Familiarise themselves with the guidance and to take any actions which they may need to prepare their dispensing teams; and
• Check with their professional indemnity insurance providers to ensure that cover applies to supplies made in accordance with SSPs.
Community Pharmacy NI has welcomed the announcement of £13.25m in funding for the community pharmacy network by the Department of Health.
Community
Pharmacy NI is the professional membership body which represents over 500 local
community pharmacies across Northern Ireland.
This
funding boost comes amidst huge strain placed on the Health Service during the
recent surge of the virus and the challenges now faced by the Health and Social
Care estate in rebuilding and transforming services as the pandemic
subsides.
The
funding allocation is set to help sustain and expand transformative services
provided by community pharmacists, building on their response to the Covid-19
pandemic whilst at the same time going some way in easing workforce pressures
and financial uncertainty.
Chief Executive of Community Pharmacy NI, Gerard Greene said:
“We
welcome the announcement from the Department of Health. This funding will allow
the community pharmacy network to sustain and develop services to build upon its
vital, frontline role. This allocation signals a move forward for community
pharmacy as a key service in the new post-Covid health and social care system
supporting important service provision to patients. It is a clear recognition
of the critical role of the sector, not only in the safe supply of medicines,
but as the fabric which holds local communities together in times of crisis.”
“Community Pharmacy NI would like to thank the Health Minister, Robin Swann MLA, for his commitment to the community pharmacy network. We are only too aware of the extreme pressures the health system has faced recently. Despite only being in post as Health Minister since the return of the Assembly earlier this year, he has listened, and prioritised community pharmacy and we must acknowledge his commitment in finding solutions.”
Health Minister Robin Swann is joined at the community funding announcement by DoH, HSCB and CPNI representatives.
“We
also commend the work of the officials in the Department of Health and HSCB who
have worked collaboratively with CPNI in securing this funding, which will have
a transformative and positive impact for patients here.”
“From
the very beginning of the pandemic, community pharmacists have worked night and
day to support their local communities. During the recent months, it is clear
that the community pharmacy network rose to the professional challenges and
adapted almost overnight to keep the flow of vital medicines to patients
managing conditions in addition to those presenting symptoms at pharmacies who
were unable to access their GP.”
“This
funding boost is hugely positive and will enable community pharmacy to address
immediate pressures and help with the challenges of the post-Covid Health
Service, assisting community pharmacy to provide even more services to ensure
our communities are served and supported and that public health is protected.”
Community
Pharmacy NI Chair, James McCaughan added:
“From
the earliest stages of the Covid-19 health crisis, community pharmacists were
all too aware that they were at the frontline of the healthcare response. We
saw an incredible surge of patients going to local community pharmacies across
NI to seek advice and obtain vital medicines.”
“The
pandemic highlighted the agility of our network, with pharmacies changing
overnight in many cases. New layouts were designed, Perspex screens were
erected, social distancing measures implemented, and stocks of PPE were provided
to ensure both public and staff safety so that community pharmacies were open,
accessible and could look after patients.”
“The
pressures of the pandemic have had an emotional and physical toll on many of
our colleagues, but it has also shone a light on their passion and energy for
our local communities and our commitment to ensure support and care is provided
at all times.”
“Community
pharmacy is the heartbeat of our neighbourhoods, with many of our patients
coming to us when they needed us most. This new funding allocation shows the
Department of Health’s commitment to ensuring community pharmacy is a key
component to the rebuilding of the Health Service. We welcome the funding news
today and look forward to maintaining and expanding on our services in future.”
The arrival of COVID-19 in March 2020 transformed the local community pharmacy landscape overnight. Working practices quickly changed, unfamiliar physical adaptions were put in place with an unprecedented spike in workload needing to be managed.
Throughout this time, community pharmacists continued to be the most accessible healthcare professional in primary care. We would like to thank the community pharmacy teams for their professionalism and dedication as they supported their local communities in the face of a public health emergency of which none of us have seen in our lifetime.
We would also like to extend our thanks to everyone who has shown their appreciation for their local community pharmacy in the past weeks and months. From kind words, cakes, cards and drawings, it has meant a lot to our amazing community pharmacy teams!
Thank you! #pharmacyheroes
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.